Bird Flu Vaccinations Remain Inactive

According to NBC News, on December 11, 2024, the U.S. administration informed the media that there are no active plans to authorize the distribution of avian influenza pandemic (bird flu) vaccines.

This news is similar to what the U.S. Centers for Disease Control and Prevention stated on June 27, 2024, when it confirmed its avian vaccination program was inactive.

Previously, the U.S. National Influenza Vaccine Modernization Strategy and the American Pandemic Preparedness Plan outlined priorities for avian influenza vaccines.

Over the past few years, the U.S. FDA has approved one vaccine (CSL Seqirus Inc. Audenz™), and the U.S. government has funded various avian influenza vaccine initiatives.

In Europe, CSL Seqirus announced on June 11, 2024, that it would provide 665,000 pre-pandemic (zoonotic) vaccines to fifteen E.U. and EEA Member States. Seqirus UK Ltd has an EU-wide modified marketing authorization for this avian influenza vaccine for use in adults.